Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

The pericapsular nerve group (PENG) block targets the nerves innervating the anterior hip surface; however, few studies on this technique are currently available. We investigated the effects of the PENG block on postoperative opioid consumption after a hip surgery. This was a randomized, double-blin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pain Research and Management 2022-12, Vol.2022, p.6022380-10
Hauptverfasser: Chung, Chan Jong, Eom, Deuk Won, Lee, Tae Young, Park, Sang Yoong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue
container_start_page 6022380
container_title Pain Research and Management
container_volume 2022
creator Chung, Chan Jong
Eom, Deuk Won
Lee, Tae Young
Park, Sang Yoong
description The pericapsular nerve group (PENG) block targets the nerves innervating the anterior hip surface; however, few studies on this technique are currently available. We investigated the effects of the PENG block on postoperative opioid consumption after a hip surgery. This was a randomized, double-blind, placebo-controlled study conducted at a single institution. Fifty patients undergoing hip surgery were randomly allocated, 25 in each group, to receive a PENG block either using 25 mL of 0.5% ropivacaine (PENG group) or 25 mL of saline (control group). The primary outcome was the total opioid consumption 24 h postoperatively. The secondary outcomes were postoperative pain scores, time to first opioid demand, sensory block efficiency, quadriceps muscle strength, complications, and patient satisfaction. Compared with those in the control group, patients in the PENG group had a significantly lower total opioid consumption 24 h postoperatively (440.72 ± 242.20 μg vs. 611.07 ± 313.89 μg, P = 0.037) and significantly lower pain scores at 30 min postblock and 6 postoperatively (P
doi_str_mv 10.1155/2022/6022380
format Article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9780006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A814686374</galeid><doaj_id>oai_doaj_org_article_9ef43c50ebaa459abc2eafff279be379</doaj_id><sourcerecordid>A814686374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c612t-c1a2b49716e1f8b6b8c766108ded02078452ef7a469f2b2c3482c3168f77a8363</originalsourceid><addsrcrecordid>eNp9kt9r1TAUx4sobk7ffJaAIILrlqRtku5BuLvqNhhuzPkc0vTk3sy0qWm7MZ_9w013r3NXRAL5cfLJ9-QcvknykuA9Qopin2JK91mcMoEfJdukJCIlBc0exz3FWco4K7aSZ31_hXFOBM6eJlsZK1iZM7qd_LyAetRQo7POelujuW_7sekG61t0Y4clOodgter60amAPkO4BnQU_NihQ-f1N2R8QMe2Q1_GsIBwe4Bm6EK1tW_sD6h30Qc_Vg7SQ2fbeDp3SkPl05hkCN65mPYyWOWeJ0-Mcj28WK87yddPHy_nx-np2dHJfHaaakbokGqiaJWXnDAgRlSsEpozRrCoocYUc5EXFAxXOSsNrajOchEnwoThXImMZTvJyUq39upKdsE2KtxKr6y8C_iwkCoMVjuQJZg80wWGSqm8KFWlKShjDOVlBRkvo9b7lVY3Vg3UGmJJym2Ibt60dikX_lqWXGCMp8-8XQsE_32EfpCN7TU4p1rwYy8pL0RWcEqnXK__Qq_8GNrYqjsK00ixP9RCxQJsa3zMqydRORMkZ4JlPI_U3j-oOGporPYtGBvjGw_ePHiwBOWGZe_dOFmk3wR3V6AOvu8DmPtmECwnq8rJqnJt1Yi_etjAe_i3NyPwbgUso3nUjf2_3C_UiO63</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758027226</pqid></control><display><type>article</type><title>Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Chung, Chan Jong ; Eom, Deuk Won ; Lee, Tae Young ; Park, Sang Yoong</creator><contributor>Rakhshan, Vahid ; Vahid Rakhshan</contributor><creatorcontrib>Chung, Chan Jong ; Eom, Deuk Won ; Lee, Tae Young ; Park, Sang Yoong ; Rakhshan, Vahid ; Vahid Rakhshan</creatorcontrib><description>The pericapsular nerve group (PENG) block targets the nerves innervating the anterior hip surface; however, few studies on this technique are currently available. We investigated the effects of the PENG block on postoperative opioid consumption after a hip surgery. This was a randomized, double-blind, placebo-controlled study conducted at a single institution. Fifty patients undergoing hip surgery were randomly allocated, 25 in each group, to receive a PENG block either using 25 mL of 0.5% ropivacaine (PENG group) or 25 mL of saline (control group). The primary outcome was the total opioid consumption 24 h postoperatively. The secondary outcomes were postoperative pain scores, time to first opioid demand, sensory block efficiency, quadriceps muscle strength, complications, and patient satisfaction. Compared with those in the control group, patients in the PENG group had a significantly lower total opioid consumption 24 h postoperatively (440.72 ± 242.20 μg vs. 611.07 ± 313.89 μg, P = 0.037) and significantly lower pain scores at 30 min postblock and 6 postoperatively (P&lt;0.001 and P&lt;0.001, respectively). The time to first opioid demand was significantly shorter in the control group than in the PENG group P&lt;0.001. Sensory block effectiveness was better in the PENG group 30 min postblock and 6 and 12 h postoperatively than in the control group. Patient satisfaction was also better in the PENG group than in the control group. There were no differences in the other outcomes. The PENG block reduced the total opioid consumption in the first 24 h after hip surgery with no significant effects on quadriceps muscle strength and complication rate. This study was registered at the Korea Clinical Research Information Service (cris.nih.go.kr; Reg. No. KCT0006348) on July 16, 2021.</description><identifier>ISSN: 1203-6765</identifier><identifier>EISSN: 1918-1523</identifier><identifier>DOI: 10.1155/2022/6022380</identifier><identifier>PMID: 36569462</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Analgesics ; Analgesics, Opioid - therapeutic use ; Double-Blind Method ; Double-blind studies ; Femoral Nerve ; Fentanyl ; Fracture fixation ; Fractures ; General anesthesia ; Hip joint ; Humans ; Medical personnel ; Medical research ; Medicine, Experimental ; Narcotics ; Nerve block ; Nerve Block - methods ; Opioids ; Pain ; Pain, Postoperative - drug therapy ; Pain, Postoperative - etiology ; Patient satisfaction ; Physiological aspects ; Ropivacaine ; Surgery ; Testing ; Ultrasonic imaging</subject><ispartof>Pain Research and Management, 2022-12, Vol.2022, p.6022380-10</ispartof><rights>Copyright © 2022 Chan Jong Chung et al.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2022 Chan Jong Chung et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Chan Jong Chung et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c612t-c1a2b49716e1f8b6b8c766108ded02078452ef7a469f2b2c3482c3168f77a8363</citedby><cites>FETCH-LOGICAL-c612t-c1a2b49716e1f8b6b8c766108ded02078452ef7a469f2b2c3482c3168f77a8363</cites><orcidid>0000-0002-0919-1398 ; 0000-0002-9241-9735 ; 0000-0002-0236-7135 ; 0000-0001-7495-8025</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780006/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780006/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,878,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36569462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Rakhshan, Vahid</contributor><contributor>Vahid Rakhshan</contributor><creatorcontrib>Chung, Chan Jong</creatorcontrib><creatorcontrib>Eom, Deuk Won</creatorcontrib><creatorcontrib>Lee, Tae Young</creatorcontrib><creatorcontrib>Park, Sang Yoong</creatorcontrib><title>Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial</title><title>Pain Research and Management</title><addtitle>Pain Res Manag</addtitle><description>The pericapsular nerve group (PENG) block targets the nerves innervating the anterior hip surface; however, few studies on this technique are currently available. We investigated the effects of the PENG block on postoperative opioid consumption after a hip surgery. This was a randomized, double-blind, placebo-controlled study conducted at a single institution. Fifty patients undergoing hip surgery were randomly allocated, 25 in each group, to receive a PENG block either using 25 mL of 0.5% ropivacaine (PENG group) or 25 mL of saline (control group). The primary outcome was the total opioid consumption 24 h postoperatively. The secondary outcomes were postoperative pain scores, time to first opioid demand, sensory block efficiency, quadriceps muscle strength, complications, and patient satisfaction. Compared with those in the control group, patients in the PENG group had a significantly lower total opioid consumption 24 h postoperatively (440.72 ± 242.20 μg vs. 611.07 ± 313.89 μg, P = 0.037) and significantly lower pain scores at 30 min postblock and 6 postoperatively (P&lt;0.001 and P&lt;0.001, respectively). The time to first opioid demand was significantly shorter in the control group than in the PENG group P&lt;0.001. Sensory block effectiveness was better in the PENG group 30 min postblock and 6 and 12 h postoperatively than in the control group. Patient satisfaction was also better in the PENG group than in the control group. There were no differences in the other outcomes. The PENG block reduced the total opioid consumption in the first 24 h after hip surgery with no significant effects on quadriceps muscle strength and complication rate. This study was registered at the Korea Clinical Research Information Service (cris.nih.go.kr; Reg. No. KCT0006348) on July 16, 2021.</description><subject>Analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Double-blind studies</subject><subject>Femoral Nerve</subject><subject>Fentanyl</subject><subject>Fracture fixation</subject><subject>Fractures</subject><subject>General anesthesia</subject><subject>Hip joint</subject><subject>Humans</subject><subject>Medical personnel</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Narcotics</subject><subject>Nerve block</subject><subject>Nerve Block - methods</subject><subject>Opioids</subject><subject>Pain</subject><subject>Pain, Postoperative - drug therapy</subject><subject>Pain, Postoperative - etiology</subject><subject>Patient satisfaction</subject><subject>Physiological aspects</subject><subject>Ropivacaine</subject><subject>Surgery</subject><subject>Testing</subject><subject>Ultrasonic imaging</subject><issn>1203-6765</issn><issn>1918-1523</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNp9kt9r1TAUx4sobk7ffJaAIILrlqRtku5BuLvqNhhuzPkc0vTk3sy0qWm7MZ_9w013r3NXRAL5cfLJ9-QcvknykuA9Qopin2JK91mcMoEfJdukJCIlBc0exz3FWco4K7aSZ31_hXFOBM6eJlsZK1iZM7qd_LyAetRQo7POelujuW_7sekG61t0Y4clOodgter60amAPkO4BnQU_NihQ-f1N2R8QMe2Q1_GsIBwe4Bm6EK1tW_sD6h30Qc_Vg7SQ2fbeDp3SkPl05hkCN65mPYyWOWeJ0-Mcj28WK87yddPHy_nx-np2dHJfHaaakbokGqiaJWXnDAgRlSsEpozRrCoocYUc5EXFAxXOSsNrajOchEnwoThXImMZTvJyUq39upKdsE2KtxKr6y8C_iwkCoMVjuQJZg80wWGSqm8KFWlKShjDOVlBRkvo9b7lVY3Vg3UGmJJym2Ibt60dikX_lqWXGCMp8-8XQsE_32EfpCN7TU4p1rwYy8pL0RWcEqnXK__Qq_8GNrYqjsK00ixP9RCxQJsa3zMqydRORMkZ4JlPI_U3j-oOGporPYtGBvjGw_ePHiwBOWGZe_dOFmk3wR3V6AOvu8DmPtmECwnq8rJqnJt1Yi_etjAe_i3NyPwbgUso3nUjf2_3C_UiO63</recordid><startdate>20221215</startdate><enddate>20221215</enddate><creator>Chung, Chan Jong</creator><creator>Eom, Deuk Won</creator><creator>Lee, Tae Young</creator><creator>Park, Sang Yoong</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M3G</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0919-1398</orcidid><orcidid>https://orcid.org/0000-0002-9241-9735</orcidid><orcidid>https://orcid.org/0000-0002-0236-7135</orcidid><orcidid>https://orcid.org/0000-0001-7495-8025</orcidid></search><sort><creationdate>20221215</creationdate><title>Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial</title><author>Chung, Chan Jong ; Eom, Deuk Won ; Lee, Tae Young ; Park, Sang Yoong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c612t-c1a2b49716e1f8b6b8c766108ded02078452ef7a469f2b2c3482c3168f77a8363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Double-blind studies</topic><topic>Femoral Nerve</topic><topic>Fentanyl</topic><topic>Fracture fixation</topic><topic>Fractures</topic><topic>General anesthesia</topic><topic>Hip joint</topic><topic>Humans</topic><topic>Medical personnel</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Narcotics</topic><topic>Nerve block</topic><topic>Nerve Block - methods</topic><topic>Opioids</topic><topic>Pain</topic><topic>Pain, Postoperative - drug therapy</topic><topic>Pain, Postoperative - etiology</topic><topic>Patient satisfaction</topic><topic>Physiological aspects</topic><topic>Ropivacaine</topic><topic>Surgery</topic><topic>Testing</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chung, Chan Jong</creatorcontrib><creatorcontrib>Eom, Deuk Won</creatorcontrib><creatorcontrib>Lee, Tae Young</creatorcontrib><creatorcontrib>Park, Sang Yoong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pain Research and Management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chung, Chan Jong</au><au>Eom, Deuk Won</au><au>Lee, Tae Young</au><au>Park, Sang Yoong</au><au>Rakhshan, Vahid</au><au>Vahid Rakhshan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial</atitle><jtitle>Pain Research and Management</jtitle><addtitle>Pain Res Manag</addtitle><date>2022-12-15</date><risdate>2022</risdate><volume>2022</volume><spage>6022380</spage><epage>10</epage><pages>6022380-10</pages><issn>1203-6765</issn><eissn>1918-1523</eissn><abstract>The pericapsular nerve group (PENG) block targets the nerves innervating the anterior hip surface; however, few studies on this technique are currently available. We investigated the effects of the PENG block on postoperative opioid consumption after a hip surgery. This was a randomized, double-blind, placebo-controlled study conducted at a single institution. Fifty patients undergoing hip surgery were randomly allocated, 25 in each group, to receive a PENG block either using 25 mL of 0.5% ropivacaine (PENG group) or 25 mL of saline (control group). The primary outcome was the total opioid consumption 24 h postoperatively. The secondary outcomes were postoperative pain scores, time to first opioid demand, sensory block efficiency, quadriceps muscle strength, complications, and patient satisfaction. Compared with those in the control group, patients in the PENG group had a significantly lower total opioid consumption 24 h postoperatively (440.72 ± 242.20 μg vs. 611.07 ± 313.89 μg, P = 0.037) and significantly lower pain scores at 30 min postblock and 6 postoperatively (P&lt;0.001 and P&lt;0.001, respectively). The time to first opioid demand was significantly shorter in the control group than in the PENG group P&lt;0.001. Sensory block effectiveness was better in the PENG group 30 min postblock and 6 and 12 h postoperatively than in the control group. Patient satisfaction was also better in the PENG group than in the control group. There were no differences in the other outcomes. The PENG block reduced the total opioid consumption in the first 24 h after hip surgery with no significant effects on quadriceps muscle strength and complication rate. This study was registered at the Korea Clinical Research Information Service (cris.nih.go.kr; Reg. No. KCT0006348) on July 16, 2021.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>36569462</pmid><doi>10.1155/2022/6022380</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-0919-1398</orcidid><orcidid>https://orcid.org/0000-0002-9241-9735</orcidid><orcidid>https://orcid.org/0000-0002-0236-7135</orcidid><orcidid>https://orcid.org/0000-0001-7495-8025</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1203-6765
ispartof Pain Research and Management, 2022-12, Vol.2022, p.6022380-10
issn 1203-6765
1918-1523
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9780006
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection
subjects Analgesics
Analgesics, Opioid - therapeutic use
Double-Blind Method
Double-blind studies
Femoral Nerve
Fentanyl
Fracture fixation
Fractures
General anesthesia
Hip joint
Humans
Medical personnel
Medical research
Medicine, Experimental
Narcotics
Nerve block
Nerve Block - methods
Opioids
Pain
Pain, Postoperative - drug therapy
Pain, Postoperative - etiology
Patient satisfaction
Physiological aspects
Ropivacaine
Surgery
Testing
Ultrasonic imaging
title Reduced Opioid Consumption with Pericapsular Nerve Group Block for Hip Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T23%3A17%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Opioid%20Consumption%20with%20Pericapsular%20Nerve%20Group%20Block%20for%20Hip%20Surgery:%20A%20Randomized,%20Double-Blind,%20Placebo-Controlled%20Trial&rft.jtitle=Pain%20Research%20and%20Management&rft.au=Chung,%20Chan%20Jong&rft.date=2022-12-15&rft.volume=2022&rft.spage=6022380&rft.epage=10&rft.pages=6022380-10&rft.issn=1203-6765&rft.eissn=1918-1523&rft_id=info:doi/10.1155/2022/6022380&rft_dat=%3Cgale_doaj_%3EA814686374%3C/gale_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2758027226&rft_id=info:pmid/36569462&rft_galeid=A814686374&rft_doaj_id=oai_doaj_org_article_9ef43c50ebaa459abc2eafff279be379&rfr_iscdi=true